[
  {
    "title": "Trump Trade: President to sign EO on DOE, weighing Chevron license extension",
    "published": 1742566575,
    "posting_price": 105.16000366,
    "close_price": 107.08000183,
    "percent_change": 1.82578747
  },
  {
    "title": "Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)",
    "published": 1742547929,
    "posting_price": 105.16000366,
    "close_price": 107.08000183,
    "percent_change": 1.82578747
  },
  {
    "title": "Oppenheimer doesn\u2019t see threat to Gilead estimates after HHS plans for HIV cuts",
    "published": 1742482849,
    "posting_price": 106.83000183,
    "close_price": 105.87000275,
    "percent_change": -0.89862311
  },
  {
    "title": "Trump Trade: Reciprocal tariffs still to start on April 2",
    "published": 1742479258,
    "posting_price": 106.83000183,
    "close_price": 105.87000275,
    "percent_change": -0.89862311
  },
  {
    "title": "Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet",
    "published": 1742477410,
    "posting_price": 106.83000183,
    "close_price": 105.87000275,
    "percent_change": -0.89862311
  },
  {
    "title": "These Stocks Moved the Most Today: Nvidia, Tesla, Boeing, Autodesk, Gilead, Signet, Williams-Sonoma, and More",
    "published": 1742417220,
    "posting_price": 109.69000244,
    "close_price": 107.51000214,
    "percent_change": -1.98741932
  },
  {
    "title": "FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review",
    "published": 1742397180,
    "posting_price": 109.69000244,
    "close_price": 107.51000214,
    "percent_change": -1.98741932
  },
  {
    "title": "Buy 3 U.S. Giants Flying High Year to Date Defying Severe Volatility",
    "published": 1742393220,
    "posting_price": 109.69000244,
    "close_price": 107.51000214,
    "percent_change": -1.98741932
  },
  {
    "title": "Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?",
    "published": 1713182400,
    "posting_price": 65.79970395,
    "close_price": 65.29852295,
    "percent_change": -0.76167668
  },
  {
    "title": "GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA",
    "published": 1713157560,
    "posting_price": 65.79970395,
    "close_price": 65.29852295,
    "percent_change": -0.76167668
  },
  {
    "title": "GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG KONG",
    "published": 1713154920,
    "posting_price": 65.79970395,
    "close_price": 65.29852295,
    "percent_change": -0.76167668
  },
  {
    "title": "Gilead Sciences (GILD) Stock Moves -0.84%: What You Should Know",
    "published": 1712959219,
    "posting_price": 66.04066307,
    "close_price": 65.60694885,
    "percent_change": -0.65673814
  },
  {
    "title": "Stocks with the highest swings in option premium price over 3 months - JPM",
    "published": 1712915280,
    "posting_price": 66.04066307,
    "close_price": 65.60694885,
    "percent_change": -0.65673814
  },
  {
    "title": "U.S. Wide-Moat Stocks On Sale - The April 2024 Heat Map",
    "published": 1712898708,
    "posting_price": 66.04066307,
    "close_price": 65.60694885,
    "percent_change": -0.65673814
  },
  {
    "title": "Attractive call buying opportunities for Russell 1000 stocks - JPM",
    "published": 1712839980,
    "posting_price": 65.98283485,
    "close_price": 66.16596222,
    "percent_change": 0.27753789
  },
  {
    "title": "GILD May 31st Options Begin Trading",
    "published": 1712831760,
    "posting_price": 65.98283485,
    "close_price": 66.16596222,
    "percent_change": 0.27753789
  },
  {
    "title": "Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter",
    "published": 1712821740,
    "posting_price": 65.98283485,
    "close_price": 66.16596222,
    "percent_change": 0.27753789
  },
  {
    "title": "Gilead Sciences: Robust HIV Business and Oncology Growth Potential Justify Buy Rating",
    "published": 1712811420,
    "posting_price": 65.98283485,
    "close_price": 66.16596222,
    "percent_change": 0.27753789
  },
  {
    "title": "12 Best Depressed Stocks To Buy in 2024",
    "published": 1712786947,
    "posting_price": 67.23580127,
    "close_price": 65.65514374,
    "percent_change": -2.35091648
  },
  {
    "title": "ClearBridge Value Equity Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712753400,
    "posting_price": 67.23580127,
    "close_price": 65.65514374,
    "percent_change": -2.35091648
  },
  {
    "title": "Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider",
    "published": 1712700919,
    "posting_price": 66.65751127,
    "close_price": 67.4092865,
    "percent_change": 1.12781773
  },
  {
    "title": "3 Stocks at 52-Week Lows Poised for a Powerful Rebound",
    "published": 1712688017,
    "posting_price": 66.65751127,
    "close_price": 67.4092865,
    "percent_change": 1.12781773
  },
  {
    "title": "10 Health Care Stocks With Whale Alerts In Today's Session",
    "published": 1712666400,
    "posting_price": 66.65751127,
    "close_price": 67.4092865,
    "percent_change": 1.12781773
  },
  {
    "title": "11 Best Biotech ETFs To Buy",
    "published": 1712662637,
    "posting_price": 66.65751127,
    "close_price": 67.4092865,
    "percent_change": 1.12781773
  },
  {
    "title": "Madrigal announces US launch of NASH/MASH drug Rezdiffra",
    "published": 1712653680,
    "posting_price": 66.65751127,
    "close_price": 67.4092865,
    "percent_change": 1.12781773
  },
  {
    "title": "Unusually active option classes on open April 9th",
    "published": 1712652060,
    "posting_price": 66.65751127,
    "close_price": 67.4092865,
    "percent_change": 1.12781773
  },
  {
    "title": "Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024",
    "published": 1712606700,
    "posting_price": 66.55149673,
    "close_price": 66.90810394,
    "percent_change": 0.5358365
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Gilead Sciences (GILD) and Agios Pharma (AGIO)",
    "published": 1712569860,
    "posting_price": 66.55149673,
    "close_price": 66.90810394,
    "percent_change": 0.5358365
  },
  {
    "title": "Fly Insider: Xilio, Aerovate among week\u00e2\ufffd\ufffd\ufffd\ufffds notable insider trades",
    "published": 1712542680,
    "posting_price": 66.55149673,
    "close_price": 66.90810394,
    "percent_change": 0.5358365
  },
  {
    "title": "Starbucks, Gilead And Ambev Are At 52-Week Lows: Should You Buy The Dip?",
    "published": 1712541180,
    "posting_price": 66.55149673,
    "close_price": 66.90810394,
    "percent_change": 0.5358365
  },
  {
    "title": "3 No-Brainer Dividend Stocks to Buy in April",
    "published": 1712400540
  },
  {
    "title": "ClearBridge Dividend Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712385900
  },
  {
    "title": "Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows",
    "published": 1712320200,
    "posting_price": 67.16834488,
    "close_price": 67.06232452,
    "percent_change": -0.15784275
  },
  {
    "title": "GILD Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 4.4% Yield",
    "published": 1712298900,
    "posting_price": 67.16834488,
    "close_price": 67.06232452,
    "percent_change": -0.15784275
  },
  {
    "title": "Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space",
    "published": 1712249878,
    "posting_price": 68.66224543,
    "close_price": 67.03340149,
    "percent_change": -2.37225557
  },
  {
    "title": "May 24th Options Now Available For Gilead Sciences (GILD)",
    "published": 1712224920,
    "posting_price": 68.66224543,
    "close_price": 67.03340149,
    "percent_change": -2.37225557
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It",
    "published": 1712149210,
    "posting_price": 69.39474933,
    "close_price": 68.32491302,
    "percent_change": -1.54166752
  },
  {
    "title": "10 Health Care Stocks Whale Activity In Today's Session",
    "published": 1712148060,
    "posting_price": 69.39474933,
    "close_price": 68.32491302,
    "percent_change": -1.54166752
  },
  {
    "title": "If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,000 Today",
    "published": 1712136780,
    "posting_price": 69.39474933,
    "close_price": 68.32491302,
    "percent_change": -1.54166752
  },
  {
    "title": "Gilead Sciences (GILD) Dips More Than Broader Market: What You Should Know",
    "published": 1712095218,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "Insider Sell: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)",
    "published": 1712057400,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "Gilead Sciences Champions Equal Pay",
    "published": 1712045760,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "Nurix Therapeutics, Gilead Sciences Extend Strategic Collaboration",
    "published": 1712042794,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "Gilead, Nurix extend research pact for two years",
    "published": 1712042760,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "IN BRIEF: Guild Esports jumps on USD250,000 loan",
    "published": 1712039220,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "Nurix Therapeutics announces extension of collaboration with Gilead",
    "published": 1712038380,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "5 Healthcare Stocks to Buy for 2024",
    "published": 1712028660,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "My April Dividend Stock Buys With Yields Up To 12%",
    "published": 1712024220,
    "posting_price": 70.18508,
    "close_price": 69.48149109,
    "percent_change": -1.00247647
  },
  {
    "title": "Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst",
    "published": 1711935540,
    "posting_price": 70.57059825,
    "close_price": 70.24289703,
    "percent_change": -0.46435942
  }
]